Original Research
Accepted on 18 Feb 2026
GuiLingJi ameliorates mild cognitive impairment by targeting unsaturated fatty acid metabolism to inhibit GPR120/NF-κB mediated neuroinflammation
in Ethnopharmacology
Original Research
Accepted on 18 Feb 2026
in Ethnopharmacology
Original Research
Accepted on 18 Feb 2026
in Bone Research
Retraction
Accepted on 18 Feb 2026
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 18 Feb 2026
in Ethnopharmacology
Mini Review
Accepted on 18 Feb 2026
in Digital Impacts
Original Research
Accepted on 18 Feb 2026
in Pediatric Nephrology
Editorial
Accepted on 18 Feb 2026
in Endovascular and Interventional Neurology
Original Research
Accepted on 18 Feb 2026
in Ethnopharmacology
Original Research
Accepted on 18 Feb 2026
in Assessment, Testing and Applied Measurement
Original Research
Accepted on 18 Feb 2026
in Educational Psychology
Review
Accepted on 18 Feb 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 18 Feb 2026
in Alzheimer's Disease and Related Dementias
Editorial
Accepted on 18 Feb 2026
in Human and Medical Genomics
Original Research
Accepted on 18 Feb 2026
in Sport Psychology
Original Research
Accepted on 18 Feb 2026
in Freshwater Science
Original Research
Accepted on 18 Feb 2026
in Inflammation